$12.380
-0.035 (-0.28%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
HCM-Prognose durch Analyse ähnlicher Charts
Alphio's HCM stock price prediction model matches the current HUTCHMED (China) Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.44 (+0.50%). The 1-week path is $12.44 (+0.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich HUTCHMED (China) Ltd-Aktien kaufen?
HUTCHMED (China) Ltd is a good buy right now, primarily driven by its recent conditional approval for Fanregratinib, which is expected to enhance revenue growth. The current price is $12.38, and the forward P/E ratio is 14.41, indicating a more favorable valuation compared to its historical performance. Additionally, the stock has shown a 20-day change of +11.23%, suggesting positive momentum. However, the main risk is its high P/E ratio of 1103.79, which indicates potential overvaluation if future earnings do not meet expectations.
HCM schloss am Friday bei $12.38, nachdem der Kurs -0.28% fallen
HUTCHMED (China) Ltd (HCM) last closed at $12.38, losing -0.28%. These facts feed the 1-day and 1-week HCM price prediction above.
Analystenkonsens
HUTCHMED (China) Ltd (HCM): 4 Kaufen, 0 Halten, 0 Verkaufen. Ausblick: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Prognose-Treiber
Die Prognose-Treiber von HUTCHMED (China) Ltd (HCM) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf HCM am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für HCM
Historically the probability of a positive August return for HCM is 53.97%. October offers the highest probability of a positive month at 82.61%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.